#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	22930	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2182	1033.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	1304	C,A	1244,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	22930	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2182	1033.7	0	HET	.	.	.	C207T,G,A	.	207	207	C	435	435	C	1252	C,T,G,A	924,256,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	22930	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2182	1033.7	0	HET	.	.	.	C451T	.	451	451	C	679	679	C	1322	C,T	635,634	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	42610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3571	1178.9	0	.	n	.	0	T695C	SNP	695	695	T	1018	1018	C	1308	C,T,A	1255,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	42610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3571	1178.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2294	2294	C	1354	C,G,T	1288,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	42610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3571	1178.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2368	2368	A	1398	A	1339	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	42610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3571	1178.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2920	2920	C	1371	C	1315	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	42610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3571	1178.9	0	HET	.	.	.	A1638G	.	1638	1638	A	1961	1961	A	1318	A,G	685,585	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	42610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3571	1178.9	0	HET	.	.	.	C1811T	.	1811	1811	C	2134	2134	C	1376	C,T	936,376	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2850	folP	855	855	100.0	folP.l15.c4.ctg.1	1558	180.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1055	1057	AGC	284;284;283	A;G;C	272;272;270	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7916	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3454	226.5	1	SNP	p	S91F	1	.	.	271	273	TTC	575	577	TTC	254;250;252	T;T;C,G	246;244;243,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7916	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3454	226.5	1	SNP	p	G95N	0	.	.	283	285	GGC	587	589	GGC	247;245;248	G;G;C	234;235;237	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7916	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3454	226.5	1	SNP	p	D95G	1	.	.	283	285	GGC	587	589	GGC	247;245;248	G;G;C	234;235;237	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2518	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1252	198.6	1	SNP	p	G45D	0	.	.	133	135	GGC	424	426	GGC	333;330;327	G;G;C	318;316;314	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1288	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	893	140.6	0	.	n	.	0	A197.	DEL	197	197	A	580	580	A	281	A	271	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7134	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3075	229.4	1	SNP	p	D86N	0	.	.	256	258	GAC	594	596	GAC	300;298;300	G;A;C,A	291;282;294,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7134	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3075	229.4	1	SNP	p	R87I	0	.	.	259	261	CGT	597	599	CGT	298;297;299	C;G;T,G	294;291;288,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7134	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3075	229.4	1	SNP	p	R87W	0	.	.	259	261	CGT	597	599	CGT	298;297;299	C;G;T,G	294;291;288,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7134	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3075	229.4	1	SNP	p	S87R	1	.	.	259	261	CGT	597	599	CGT	298;297;299	C;G;T,G	294;291;288,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7134	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3075	229.4	1	SNP	p	S88P	0	.	.	262	264	TCC	600	602	TCC	300;300;299	T;C,T;C	291;295,1;293	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	6062	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2702	221.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1535	1537	GGC	315;312;309	G;G;C	304;301;292	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1249	1251	GCC	363;364;363	G;C;C	343;346;344	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1252	1254	ATG	360;356;353	A;T;G	338;333;329	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1264	1266	ACC	356;355;356	A;C;C	324;335;328	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1264	1266	ACC	356;355;356	A;C;C	324;335;328	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1765	1767	ACC	301;301;303	A,C;C;C,G	278,1;285;284,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1819	1821	GCG	290;289;287	G;C;G	279;281;281	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1819	1821	GCG	290;289;287	G;C;G	279;281;281	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1942	1944	GGT	233;230;227	G;G;T	220;217;209	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1951	1953	AGC	223;219;217	A;G,A;C	209;200,1;205	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6228	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	261.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1969	1971	CCG	175;178;177	C,G,A;C,G;G,GGC	144,10,1;145,2;140,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	8220	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3111	260.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1661	1663	CCG	270;269;272	C;C;G	256;254;252	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3404	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1935	173.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	611	611	C	240	C	221	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	4220	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1503	276.2	1	SNP	p	G120K	1	.	.	358	360	AAG	647	649	AAG	324;323;323	A,C;A;G	301,1;307;297	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	4220	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1503	276.2	1	SNP	p	N121D	0	.	.	361	363	AAC	650	652	AAC	322;319;321	A;A;C,A	305;304;300,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	4220	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1503	276.2	1	SNP	p	A121N	1	.	.	361	363	AAC	650	652	AAC	322;319;321	A;A;C,A	305;304;300,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	15062	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4797	309.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1670	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	899	182.4	1	SNP	p	V57M	1	.	.	169	171	ATG	459	461	ATG	356;360;360	A;T;G	347;347;346	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
